Memorial Sloan Kettering Cancer Center: Phase 1 study closed enrollment, 18 enrolled (Solid Tumors)
Memorial Sloan Kettering Cancer Center: Phase 1 study closed enrollment, 18 enrolled (Solid Tumors). Its enrollment of 18 is below the median of 80 (7th percentile). Dated 37 days ago, it serves as a historical benchmark. Score 30/100. As of 2026-11-05, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 18 · 7th percentile of 9,177 ClinicalTrialStartPulse records · 0.2x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Sponsor type | Academic and hospital |
| Study | Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors |
| NCT ID | NCT02498912 |
| Phase | Phase 1 |
| Status | active not recruiting |
| Conditions | Solid Tumors |
| Intervention types | procedure, drug, device, genetic |
| Target enrollment | 18 |
| Site countries | United States |
| Posted | 2015-07-15 |
| Planned start | 2015-08 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-09-29 |
| Last update posted | 2026-09-29 |
| enrollment percentile | 7th of 9,177 (median 80, 0.2x median) |
| Peer records CSV (500 US records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Memorial Sloan Kettering Cancer Center
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Memorial Sloan Kettering Cancer Center + 500 US peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-09-29
- Data refreshed: 2026-11-05
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Institutes of Health Clinical Center (CC) · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Thu, 05 Nov 2026 08:46:16 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Memorial Sloan Kettering Cancer Center and 2,595 US peers
- US ClinicalTrialStartPulse records like this one: 2,595
- Memorial Sloan Kettering Cancer Center's enrollment: 7th percentile of 9,177 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every US peer: $519,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
30 / 100 Score
- Enrollment closed: data management, monitoring and closeout ahead.
What is the ClinicalTrialStartPulse record for Memorial Sloan Kettering Cancer Center?
Memorial Sloan Kettering Cancer Center's Phase 1 study (NCT02498912) in Solid Tumors, first posted 2015-07-15: enrollment closed (active, not recruiting) (2026-09-29), in an update posted 2026-09-29.
How does Memorial Sloan Kettering Cancer Center compare to other ClinicalTrialStartPulse records?
Its enrollment of 18 is below the median (7th percentile); smaller records often move faster and face less competition. It is 37 days old, still within a typical 45-day follow-up window. Its Score of 30/100 is modest; treat it as background rather than a priority.
Memorial Sloan Kettering Cancer Center vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | US | 18 | 7th | 2026-09-29 |
| Eli Lilly and Company | US | 108 | 62nd | 2026-11-04 |
| AbbVie | US | 135 | 68th | 2026-11-04 |
| Janssen Research & Development, LLC | US | 144 | 69th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 1 ClinicalTrialStartPulse: United States sites
More US public-record feeds
U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US
How to monitor Memorial Sloan Kettering Cancer Center and peer phase 1 records
Get new ClinicalTrialStartPulse records like Memorial Sloan Kettering Cancer Center by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.